Preventive effect of rebamipide on NSAID-induced lower

Rebamipide Ophthalmic Suspension Phase II Study Group Rebamipide in the treatment of dry eye: a randomized, double-masked

Results: Healing rates at 12 weeks were % and % in the rebamipide and omeprazole groups, respectively There was no

rebamipide In this way, rebamipide counteracts some of the causes of NSAID-induced lower gastrointestinal tract injury Rebamipide has been shown to be

rebamipide The invention relates to a rebamipide tablet The rebamipide tablet is prepared from, by weight, 50%-65% of rebamipide, 15%-45% of diluents,